JO
IMI

John Overdeck’s Intermolecular, Inc. IMI Stock Holding History

John Overdeck’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-27,990
Closed -$154K – 2465
2013
Q3 		$154K Sell
27,990
-21,240
-43% -$134K ﹤0.01% 1700
2013
Q2 		$358K Buy
+49,230
New +$419K ﹤0.01% 1559

Other funds holding IMI

PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
KSC
Kendall Square Capital San Francisco, California $4.92M AUM 2.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

John Overdeck's IMI Position: Q4 2013 in Review

John Overdeck sold out of Intermolecular, Inc. (IMI) in Q4 2013, closing a stake of 27,990 shares — an estimated $154K sold.

John Overdeck first reported a position in IMI in Q2 2013 and held it in 2 quarters. The position peaked at $358K in Q2 2013. 53 funds tracked by Wall St. Rank hold IMI as of Q4 2013.

  • John Overdeck reported no remaining Intermolecular, Inc. position as of Q4 2013 after selling out during the quarter.
  • John Overdeck sold 27,990 Intermolecular, Inc. shares in Q4 2013, an estimated $154K.
  • John Overdeck first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 2 quarters.
  • John Overdeck's Intermolecular, Inc. position peaked at $358K in Q2 2013.
  • 53 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q4 2013.

Based on Two Sigma Investments's 13F filing for Q4 2013, filed 14 Feb 2014.